Cystic fibrosis and diabetes: isoLAB and isoDAB, enantiomeric carbon-branched pyrrolidine iminosugars

被引:44
作者
Best, Daniel [1 ]
Jenkinson, Sarah F. [1 ]
Saville, A. Waldo [1 ]
Alonzi, Dominic S. [3 ]
Wormald, Mark R. [3 ]
Butters, Terry D. [3 ]
Norez, Caroline [4 ]
Becq, Frederic [4 ]
Bleriot, Yves [5 ]
Adachi, Isao [2 ]
Kato, Atsushi [2 ]
Fleet, George W. J. [1 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England
[2] Toyama Univ, Dept Hosp Pharm, Toyama 9300194, Japan
[3] Univ Oxford, Oxford Glycobiol Inst, Oxford OX1 3QU, England
[4] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France
[5] Lab Synth & React Subst Nat, UMR 6514, F-86022 Poitiers, France
关键词
LOOKING-GLASS INHIBITORS; GLYCOSIDASE INHIBITORS; PHARMACOLOGICAL RESCUE; GLUCOSIDASE INHIBITOR; EPITHELIAL-CELLS; POTENT INHIBITOR; ANGYLOCALYX-BOUTIQUEANUS; GLYCOGEN-PHOSPHORYLASE; ARACHNIODES-STANDISHII; ALPHA-GLUCOSIDASES;
D O I
10.1016/j.tetlet.2010.05.131
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Acetonides are the only protecting groups used in the syntheses of isoDAB from D-ribose and of isoLAB from D-tagatose. isoDAB is a potent and highly specific competitive a-glucosidase inhibitor (for rice alpha-glucosidase, K(i) = 4 mu M for isoDAB compared to K(i) 14 mu M for DAB). isoDAB is not an whereas DAB is a potent inhibitor of glycogen phosphorylase. This is the first example of any potent inhibition of glycosidases by a carbon-branched iminosugar pyrrolidine. Although isoLAB shows no inhibition of any glycosidase, preliminary experiments suggest that isoLAB partially rescues the defective F508del-CFTR function and so may have a role in the study of cystic fibrosis. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4170 / 4174
页数:5
相关论文
共 71 条
  • [1] Glucosylated free oligosaccharides are biomarkers of endoplasmicreticulum α-glucosidase inhibition
    Alonzi, Dominic S.
    Neville, David C. A.
    Lachmann, Robin H.
    Dwek, Raymond A.
    Butters, Terry D.
    [J]. BIOCHEMICAL JOURNAL, 2008, 409 : 571 - 580
  • [2] Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-d-arabinitol
    Andersen, B
    Rassov, A
    Westergaard, N
    Lundgren, K
    [J]. BIOCHEMICAL JOURNAL, 1999, 342 : 545 - 550
  • [3] Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR
    Antigny, Fabrice
    Norez, Caroline
    Becq, Frederic
    Vandebrouck, Clarisse
    [J]. CELL CALCIUM, 2008, 43 (02) : 175 - 183
  • [4] The L-enantiomers of D-sugar-mimicking iminosugars are noncompetitive inhibitors of D-glycohydrolase?
    Asano, N
    Ikeda, K
    Yu, L
    Kato, A
    Takebayashi, K
    Adachi, I
    Kato, I
    Ouchi, H
    Takahata, H
    Fleet, GWJ
    [J]. TETRAHEDRON-ASYMMETRY, 2005, 16 (01) : 223 - 229
  • [5] Sugar-mimicking glycosidase inhibitors: bioactivity and application
    Asano, N.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (09) : 1479 - 1492
  • [6] Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application
    Asano, N
    Nash, RJ
    Molyneux, RJ
    Fleet, GWJ
    [J]. TETRAHEDRON-ASYMMETRY, 2000, 11 (08) : 1645 - 1680
  • [7] SYNTHESIS FROM D-LYXONOLACTONE OF 1,4-DIDEOXY-1,4-IMINO-L-ARABINITOL, A GLUCOSIDASE INHIBITOR WITH INVITRO ANTIVIRAL ACTIVITY
    BEHLING, JR
    CAMPBELL, AL
    BABIAK, KA
    NG, JS
    MEDICH, J
    FARID, P
    FLEET, GWJ
    [J]. TETRAHEDRON, 1993, 49 (16) : 3359 - 3366
  • [8] 2,3-O-isopropylidene-L-apiono-1,4-lactone [(3S, 4S)-3,4-dihydroxy-4-(hydroxymethyl)-3,4-di-O-isopropylidene-4,5-dihydrofuran-2(3H)-one]
    Best, Daniel
    Jenkinson, Sarah F.
    Watkin, David J.
    Booth, Kathrine V.
    Fleet, George W. J.
    [J]. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O1056 - O1057
  • [9] Looking glass inhibitors: scalable syntheses of DNJ, DMDP, and (3R)-3-hydroxy-L-bulgecinine from D-glucuronolactone and of L-DNJ, L-DMDP, and (3S)-3-hydroxy-D-bulgecinine from L-glucuronolactone. DMDP inhibits β-glucosidases and β-galactosidases whereas L-DMDP is a potent and specific inhibitor of α-glucosidases
    Best, Daniel
    Wang, Chen
    Weymouth-Wilson, Alexander C.
    Clarkson, Robert A.
    Wilson, Francis X.
    Nash, Robert J.
    Miyauchi, Saori
    Kato, Atsushi
    Fleet, George W. J.
    [J]. TETRAHEDRON-ASYMMETRY, 2010, 21 (03) : 311 - 319
  • [10] C-3- and C-4-alkylated polyhydroxypyrrolidines: Enantiospecific syntheses and glycosidase inhibitory activity
    Blanco, MJ
    Sardina, FJ
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (10) : 3411 - 3416